01.06.2025

DAX Developments in May 2025: Winners and Losers at a Glance

Market Overview in May 2025

In May 2025, significant market developments caused noticeable movement in the DAX. The performance of individual DAX stocks was very different, which is of high relevance for both private investors and small investors. The DAX itself showed strong development in the year 2025 so far: By May 20, the index was already around 20.7 percent above the previous year’s value. In May, the index moved between an opening value of approximately 22,649 points and a closing value of around 22,819 points – a moderate increase of about 0.8 percent according to forecasts. However, the actual closing prices were significantly higher at the end of May.

Biggest Losers in the DAX (May 2025)

The following companies recorded the strongest price declines among the DAX-40 stocks during the period from April 30 to May 30, 2025:

  • Sartorius vz: -7.09 %
  • Merck: -5.25 %
  • Munich Re: -5.02 %
  • BASF: -5.00 %
  • Allianz: -4.23 %

These stocks ended up at the bottom of the rankings and were the biggest flops of the month.

Biggest Winners in the DAX (May 2025)

The ranking of the top performers is not fully listed in the available sources; primarily the flop stocks are mentioned in detail. However, other reports indicate that there were also significant winners – these are usually mentioned only in summary or are not explicitly listed.

Typically, in such months with strong dynamics, stocks from the technology sector or companies with positive quarterly results often rank as the winners – however, specific names are missing in the currently available rankings for May.

Summary

Losers:

  • Sartorius vz (-7.09 %)
  • Merck (-5.25 %)
  • Munich Re (-5.02 %)
  • BASF (-5 %)
  • Allianz (-4.23 %)

Winners: Not explicitly named in current rankings; mostly technology companies or stocks with positive quarterly results.

The overall market remained robust despite individual setbacks and continued to show a positive trend throughout the year.

For private investors, it is particularly relevant to know: The performance of individual stocks can deviate significantly from the overall market – diversification remains an important tool for risk spreading. Even though some large stocks like Sartorius vz or Merck were weak, the overall index remained stable to slightly rising.

A detailed list of all top winners would be desirable; however, it is currently not available or has not been published in the main sources.